查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2107333

農業生技藥品市場：按產品類型、原料、應用方法、目標作物、地區和主要參與者分類的趨勢和預測（至 2035 年）

Agricultural Biologicals Market by Type of Product, Source of Product, Mode of Application, Type of Crop Treated, Geographical Regions and Leading Players - Trends and Forecast Till 2035
出版日期: | 出版商: Roots Analysis | 英文 310 Pages | 商品交期: 7-10個工作天內

價格

農業生技藥品市場概覽

全球農業生技藥品市場預計將從今年的 182.7 億美元成長到 2035 年的 435.3 億美元，在整個預測期內實現 10.1% 的複合年成長率。

農業生物製品市場-IMG1

農業生技藥品市場：成長與趨勢

農業生物生技藥品，例如生物農藥、生物肥料和生物促效劑，是天然來源的作物保護和營養產品，它們透過生物機制提高作物產量和土壤健康。過去十年，在氣候變遷、土壤劣化和化學殘留物監管日益嚴格的背景下，農業生技藥品已從小眾解決方案發展成為綜合作物管理的主流組成部分。

此外，全球糧食需求不斷成長、水資源短缺、害蟲抗藥性增強以及對合成農藥監管日益嚴格，都在推動生物來源替代品的普及，這些替代品既能滿足監管要求，又能提高生產力。聯合國糧食及農業組織（糧農組織）、美國環保署（EPA）、歐洲食品安全局（EFSA）和印度農業研究理事會（ICAR）等機構都強調了生物來源作物投入品在國家糧食安全和土壤健康戰略中的重要作用，從而為其商業性應用創造了有利條件。

跨國農藥生產商和專業生物來源產品研發公司正在拓展其生物來源產品組合。例如，BASF完成了對AgBiTech的收購，從而加強了其生物來源害蟲防治產品的供應鏈。同時，IPL Biologicals在古吉拉突邦新建了第三家生產工廠，使其年產能提升至7,000千公升。先正達也持續拓展其在天然化合物和微生物菌株方面的研發能力。這些趨勢表明，生物來源產品不再僅僅被視為實驗性的副業，而是被視為一個結構性的長期發展領域。這些措施預示著將對分銷合作夥伴、製劑物流以及銷售管道的經濟效益產生直接影響。

成長驅動力：支持市場擴張的因素

農業生技藥品市場的成長主要得益於對合成農藥日益嚴格的監管，旨在促進環境友善和永續農業的發展，從而加速生物來源農作物保護產品的普及。此外，對無殘留農產品的需求不斷成長，也進一步促使農民關注農業生技藥品。聯合國糧食及農業組織（FAO）估計，約有17億人居住在受人為土地劣化影響的地區，這項估計，加上永續和可再生農業的轉型，正在擴大生物肥料和生物促效劑的潛在市場規模。微生物菌株發現、發酵技術和製劑穩定性方面的不斷進步，正在改善田間均勻性，而田間均勻性長期以來一直是農民信心的障礙。

市場挑戰：阻礙進展的主要障礙

儘管農業生技藥品的應用日益廣泛，但市場仍面臨許多挑戰。生物來源製劑的田間表現會因氣候條件、土壤類型和作物種類而有所不同。與標準化的合成化學產品相比，這些因素可能會降低農民的信心。此外，監理政策也存在不一致性。生物農藥需經過明確的農藥登記流程，而生物促效劑在美國則大多無需獲得美國環保署（EPA）的正式登記，其他地區的監管規定也不一致。這導致一些檢驗的產品流入市場，對符合監管規定的研發者而言，造成了不公平的競爭環境。

農業生技藥品市場：關鍵洞察

本報告詳細分析了目前農業生技藥品市場的現狀，並為分銷仲介業者、銷售管道和農資零售商指明了潛在的​​成長機會。主要發現包括：

  • 產品來源、儲存和配方穩定性有顯著差異。由於植物性生技藥品與微生物製品相比，在儲存和活性方面通常限制較少，因此經銷商需要針對每種產品製定不同的處理程序，而不是遵循單一的低溫運輸標準。
  • 種子處理作為成長最快的應用模式，帶來了明顯的市場機會。與種子生產商和綜合作物解決方案供應商合作的公司和夥伴關係，能夠在種子處理需求擴展到更廣泛的葉面噴布和土壤施用市場之前，搶佔先機。
  • 由於生物促效劑在美國無需經過美國環保署（EPA）的正式農藥登記，且其他地區的監管框架也不一致，導致相關監管體系碎片化，進而造成大量未經核實的產品湧入市場。檢驗檢驗保證配方品質的經銷商，與那些僅以價格競爭的競爭對手相比，擁有明顯的差異化優勢。
  • 隨著亞太地區產能的擴張，以 IPL Biologicals 在古吉拉突邦的製造工廠擴建為例，對能夠促進當地監管流程並實現向分散的小規模農場市場進行最後一公里配送的本地分銷和物流合作夥伴的需求日益成長。
  • 隨著大型農藥生產商之間的整合不斷推進，例如BASF收購AgBiTech，小規模區域發展公司的進入門檻也隨之提高。另一方面，擁有專注於特定作物或地區的專業知識的經銷商正迎來新的商機，而這些商機難以被大型綜合分銷商輕易複製。
  • 在水果和堅果等高價值園藝領域，生產者越來越期望獲得產品供應以外的附加價值服務，例如農場檢測和出口認證支援。這表明，該領域的經銷商不僅在物流成本上競爭，也在技術支援方面競爭。
  • 政府主導的土壤改良計劃，例如印度的 ICAR-CRIDA 的“拯救田地運動”，直接推動了農民對生物肥料和生物來源材料的需求，為與公共部門推廣計劃合作的經銷商在糧食和豆類領域提供了政策支持和永續的需求基礎。

近期交易趨勢顯示投資者情緒高漲。

  • 產能擴大：IPL Biologicals位於古吉拉突邦多達拉的新工廠年產能增加了7,000千公升。這直接反映了其亞太供應基地多年來持續的銷售量成長。
  • 併購趨勢：BASF農業解決方案公司收購AgBiTech擴大了該公司的生物來源害蟲防治產品系列組合，並表明主要製造商之間將繼續整合。
  • 監管進展：BioPrime AgriSolutions 的 20 種生物促效劑配方獲得印度農業部的批准，表明主要新興市場的監管澄清正在加速。
  • 深化研發：先正達收購諾華的天然化合物和基因菌株庫，體現了對其獨特的微生物和植物來源物質發現平台的持續投資。

農業生技藥品市場的細分

市場規模和機會分析是根據以下參數進行細分的：

依產品類型

  • 生物農藥/生物防治
  • 生物肥料
  • 生物促效劑

按原料

  • 微生物
  • 植物萃取物
  • 其他

透過應用方法

  • 葉面噴布
  • 種子處理
  • 土壤處理
  • 其他應用方法

按目標作物

  • 穀類和豆類
  • 水果和堅果
  • 油料作物
  • 綠色飼料、蔬菜、塊莖
  • 工業作物、纖維作物和其他

按地區

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 亞太其他地區
  • 中東和北非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 其他拉丁美洲國家

其他好處

  • 免費PPT洞察包
  • 一個免費的Excel資料包，支援報告中的所有分析模組。
  • 我們提供內容客製化15%的折扣。
  • 調查團隊將進行詳細的報告說明。
  • 如果報告發布至今已超過 6 至 12 個月，我們將免費將其更新至最新版本。

目錄

第1章：序言

第2章：調查方法

第3章 市場動態

第4章 宏觀經濟指標

第5章執行摘要

第6章：引言

第7章 市場狀況

第8章：企業競爭力分析

第9章：公司簡介

  • 章節概要
  • 農業生技藥品市場的主要參與者
    • Andermatt
    • Certis Biologicals
    • Corteva Agriscience
    • Nutri-Tech Solutions
    • Novozymes
    • ProFarm
    • SQM
    • UPL
    • Vegalab
  • 農業生技藥品市場的其他公司
    • AMVAC
    • BASF
    • Bayer
    • BioSafe Systems
    • Brandt
    • Chr.
    • FBSciences
    • Grow Indigo
    • Koppert
    • Lallemand
    • PI Industries
    • Stoller
    • Syngenta
    • Valent Biosciences
    • Verdesian Life Sciences

第10章夥伴關係與合作

第11章 專利分析

第12章：波特五力模型分析

第13章 市場影響分析：促進因素、阻礙因素、機會與挑戰

第14章：全球農業生技藥品市場

第15章：農業生技藥品市場（依產品類型分類）

第16章：農業生技藥品市場（按原始材料分類）

第17章：農業生技藥品市場（依應用方法分類）

第18章：農業生技藥品市場（以目標作物分類）

第19章：農業生技藥品市場（按地區分類）

第20章 結論

第21章：高階主管洞察

第22章附錄1：表格形式數據

Product Code: RA100456

AGRICULTURAL BIOLOGICALS MARKET: OVERVIEW

As per Roots Analysis, the global agricultural biologicals market is estimated to grow from USD 18.27 billion in the current year to USD 43.53 billion by 2035, registering a CAGR of 10.1% across the forecast period.

Agricultural Biologicals Market - IMG1

Agricultural Biologicals Market: Growth and Trends

Agricultural biologicals, such as biopesticides, biofertilizers, and biostimulants are naturally derived crop protection and nutrition products that enhance crop yield and soil health through biological mechanisms. Over the past decade, agricultural biologicals have evolved from a niche solution to a mainstream component of integrated crop management, driven by climate variability, soil degradation, and stricter chemical residue regulations

Additionally, rising global food demand, water scarcity, increasing pest resistance, and stricter regulations on synthetic agrochemicals are driving the adoption of biological alternatives that improve productivity while supporting regulatory compliance. Agencies such as the Food and Agriculture Organization (FAO), the US Environmental Protection Agency (EPA), the European Food Safety Authority (EFSA) and the Indian Council of Agricultural Research (ICAR) have reinforced the role of biological crop inputs in national food-security and soil-health strategies, creating favorable conditions for commercial adoption.

Multinational agrochemical manufacturers and specialized biological product developers are expanding their biological portfolios. For instance, BASF's completed acquisition of AgBiTech to strengthen its biological insect-control offering. Meanwhile, IPL Biologicals' third manufacturing plant in Gujarat increased production capacity to 7,000 KL per year, and Syngenta's continued build-out of natural-compound and microbial-strain capabilities. These developments signal that biologicals are being treated as a structural, long-term category rather than an experimental sideline. These initiatives indicate a shift with direct implications for distribution partners, formulation logistics and channel economics.

Growth Drivers: Factors Fueling Market Expansion

Agricultural biologicals market growth is being driven by increasing regulatory restrictions on synthetic agrochemicals to promote environmentally friendly and sustainable farming, which is accelerating adoption of biological crop protection. Additionally, growing demand for residue-free produce has further shifted farmers' focus toward agricultural biologicals. Further, the push toward sustainable and regenerative agriculture, reinforced by FAO estimates that roughly 1.7 billion people live in regions affected by human-induced land degradation, is widening the addressable base for biofertilizers and biostimulants. Continued advances in microbial strain discovery, fermentation technology and formulation stability are improving field consistency, a long-standing barrier to grower confidence.

Market Challenges: Critical Barriers Hindering Progress

Although agricultural biologicals are being adopted on a large scale, the market still witnesses several challenges that need to be addressed. Field performance for biological products can vary with climatic conditions, soil type, and crop variety. These factors may limit farmer confidence relative to standardized synthetic chemistries. Regulatory treatment is also inconsistent: while biopesticides go through defined pesticide-registration pathways, biostimulants largely fall outside formal EPA registration in the US and face fragmented rules across other geographies, allowing products with unverified efficacy claims to enter the market and creating uneven competitive conditions for compliant developers.

Agricultural Biologicals Market: Key Insights

The report delves into the current state of the agricultural biologicals market and identifies potential growth opportunities for distribution partners, channel intermediaries, and agri-input retailers. Some key findings include:

  • Storage and formulation stability differ meaningfully by source of product: plant-extract biologicals generally face fewer storage and viability constraints than microbial formulations, which require distributors to maintain differentiated handling protocols across their portfolio rather than a single cold-chain standard.
  • The forecast shift toward seed treatments as the fastest-growing application mode is opening a distinct channel opportunity: companies and distributors that establish partnerships with seed manufacturers and integrated crop-solution providers are positioned to capture early-stage adoption before it reaches broad-acre foliar and soil channels.
  • Regulatory fragmentation for biostimulants, which largely fall outside formal EPA pesticide registration in the US and face inconsistent frameworks elsewhere, is allowing products with unverified efficacy claims into the market; distributors that can validate and stand behind formulation quality have a clear differentiation lever over price-only competitors.
  • Capacity build-out in Asia-Pacific, exemplified by IPL Biologicals' expanded manufacturing plant in Gujarat, is increasing the need for regional distribution and logistics partners capable of navigating local regulatory pathways and last-mile delivery into fragmented smallholder markets.
  • Consolidation among large agrochemical majors, such as BASF's acquisition of AgBiTech, is raising barriers to entry for smaller regional developers while simultaneously creating openings for niche distributors with crop-specific or geography-specific expertise that larger, generalist channel players cannot easily replicate.
  • In high-value horticultural segments such as fruits and nuts, growers increasingly expect value-added services, including on-farm trials and export-certification assistance, alongside product supply, indicating that distributors in this space are competing on technical support rather than logistics cost alone.
  • Government-backed soil-health programs, such as ICAR-CRIDA's Save the Field Campaign in India, are directly channelling farmer demand toward biofertilizers and biological inputs, giving distributors aligned with public-sector extension programs a durable, policy-supported demand base in cereals and pulses.

Recent Deal Activity Signalling Investor Momentum

  • Capacity Expansion: IPL Biologicals' new manufacturing plant in Vadodara, Gujarat lifts annual output to 7,000 KL / year, a direct proxy for sustained multi-year volume growth in the Asia-Pacific supply base.
  • M&A Activity: BASF Agricultural Solutions' completed acquisition of AgBiTech extends its biological insect-control portfolio, signaling continued consolidation among originator-scale players.
  • Regulatory Momentum: BioPrime AgriSolutions' approval for 20 biostimulant formulations from India's Ministry of Agriculture illustrates accelerating regulatory clarity in key emerging markets.
  • R&D Deepening: Syngenta's acquisition of a natural-compound and genetic-strain repository from Novartis reflects sustained investment in proprietary microbial and botanical discovery platforms.

Agricultural Biologicals Market Segments

The market sizing and opportunity analysis has been segmented across the following parameters:

By Type of Product

  • Biopesticides / Biocontrol
  • Biofertilizers
  • Biostimulants

By Source of Product

  • Microbes
  • Plant Extracts
  • Other Sources

By Mode of Application

  • Foliar Sprays
  • Seed Treatments
  • Soil Treatments
  • Other Application Methods

By Type of Crop Treated

  • Cereals and Pulses
  • Fruits and Nuts
  • Oilseeds
  • Green Fodder, Vegetables and Tubers
  • Industrial Crops, Textile Crops and Others

By Geographical Regions

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • Middle East and North Africa
  • Saudi Arabia
  • UAE
  • Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

Agricultural Biologicals Market: Key Segments

Biopesticides and Biocontrol Leads the Market

Biopesticides and biocontrol solutions currently account for the largest share of overall market share. This highest share is supported by the high economic value of crop protection and yield preservation. Further, the tightening residue regulations that favor biological alternatives to synthetic pesticides has further driving this segment growth.

In the coming years, Biofertilizers are projected to register the higher CAGR during the forecast period. This lucrative growth is largely because growers are increasingly prioritizing long-term soil health and nutrient-use efficiency, which is likely to increase the demand for biofertilizers. Further, the rising fertilizer costs and government-backed regenerative agriculture programs have supported the growth of biofertilizers segment.

Microbial Products Dominate the Market

Based on Roots Analysis market report, microbial products capture the highest market share. This highest share reflects their broad applicability across protection, fertilization and biostimulation, and their established track record on efficacy and scalability.

In the long run, plant extracts are expected to grow at a comparatively higher CAGR during the forecast period. This growth is aided by favorable storage stability and regulatory profiles relative to microbial formulations.

Foliar Sprays Hold the Highest Share of the Market

Based on the proprietary market report, Foliar sprays hold highest application share, owing to rapid, targeted delivery that integrates easily into existing spray programs. This targeted approach allows growers to rapidly correct acute nutrient deficiencies or address sudden pest and disease outbreaks in real-time, preventing severe yield drag.

On the other hand, seed treatments segment is likely to grow at a higher CAGR during the forecast period. This growth is driven by a shift toward preventive and input-efficient crop establishment strategies. Rather than relying on reactive, broad-acre foliar applications, modern agricultural systems are prioritizing localized, seed-applied solutions. This targeted approach ensures maximum early-stage protection against soil-borne pathogens and pests while drastically reducing chemical runoff, aligning operational efficiency with tightening environmental ESG standards.

Cereals and Pulses Dominate the Crop Treating Segment

Based on the Roots Analysis market report, cereals and pulses account for the highest overall market share. This highest share is driven by the sheer scale of global cultivation area and government-backed soil-health initiatives such as ICAR-CRIDA's Save the Field Campaign (Khet Bachao Abhiyan), launched in June.

On the other hand, fruits and nuts are projected to grow at the fastest CAGR during the forecast period. This rapid growth is propelled by escalating export-compliance demands and the lucrative per-acre margins in high-value horticulture, which make growers far more receptive to investing in premium biological solutions.

North America Dominates the Market and Registers Higher CAGR

North America anchors the global market, driven by a mature organic-farming infrastructure, high biological adoption rates, and robust commercial distribution channels. This dominance is further stabilized by the EPA's structured regulatory frameworks, which provide clear, predictable registration pathways for novel crop inputs.

Meanwhile, the Asia-Pacific region is projected to register the fastest CAGR during the forecast period till 2035. This highest growth is propelled by aggressive government-backed soil restoration mandates and a massive domestic push to scale manufacturing capacity in agricultural giant countries like India and China, paving the way for rapid localized production of advanced crop solutions.

Example Players in Agricultural Biologicals Market

  • AMVAC
  • Andermatt
  • BASF
  • Bayer
  • BioSafe Systems
  • Brandt
  • Certis Biologicals
  • Corteva Agriscience
  • FBSciences
  • Grow Indigo
  • Koppert Biological Systems
  • Lallemand
  • Nutri-Tech Solutions
  • Novonesis
  • PI Industries
  • ProFarm
  • SQM
  • Stoller
  • Syngenta AG
  • UPL
  • Vegalab
  • Valent Biosciences
  • Verdisian Life Sciences

Expert Interview and Industry Insights

The opinions and insights presented in this study were shaped by discussions with multiple stakeholders across the value chain. The research report features detailed transcripts of interviews held with the following industry participants:

  • President, Mid-sized Company, Switzerland
  • Global Director, Mid-sized Company, Canada
  • Sales Representative, Mid-sized Company, China

In addition, the market report includes transcripts of the following other third-party discussions:

  • Chairman of the Board, Mid-sized Company, US
  • Head of Biologics, Very Large Company, Germany
  • Agribusiness Strategist, Small Company, Brazil
  • Director of Market Innovation, Mid-sized Company, US
  • Chief Executive Officer and Co-founder, Mid-sized Company, Belgium
  • Director of Technical Marketing and Communication, Mid-sized Company, US
  • Head of Crop Protection Product Team Biologicals, Very Large Company, Germany
  • Founder and Former Chief Executive Officer, Mid-sized Company, US
  • Chief Executive Officer and President, Mid-sized Company, Spain
  • Co-founder and Chief Executive Officer, Mid-sized Company, Chile

AGRICULTURAL BIOLOGICALS MARKET: RESEARCH COVERAGE

  • Market Sizing and Opportunity Analysis: An in-depth analysis of the agricultural biologicals market, focusing on key segments, including type of product, source of product, mode of application, type of crop treated, and geographical regions.
  • Distributor and Channel Landscape: A dedicated view of how application method (foliar, seed, soil) and crop-cycle seasonality shape inventory, cold-chain and last-mile distribution requirements, directly relevant to distributors and agri-input retailers.
  • Developer Landscape: A detailed assessment of companies developing agricultural biologicals, based on parameters such as year of establishment, company size, location of headquarters, and product portfolio breadth.
  • Company Profiles: In-depth profiles of prominent players engaged in the development and commercialization of agricultural biologicals, featuring information on year of establishment, headquarters, product portfolio, and key initiatives.
  • Partnerships and Collaborations Analysis: A comprehensive assessment of partnership activity among agricultural biologicals developers, evaluated by year, partnership type, focus area, and geography, highlighting the most active companies and regional deal patterns.
  • Patent Analysis: A comprehensive analysis of patents related to agricultural biologicals, based on several relevant parameters, including publication year, application year, patent type, jurisdiction, CPC symbols, and type of applicant. The chapter further presents an assessment of the leading industry players, non-industry players, and individual assignees based on patent activity.
  • Porter's Five Forces Analysis: A qualitative assessment of the competitive dynamics within the market using Porter's Five Forces framework. The chapter evaluates the impact of five key forces, namely, the threat of new entrants, bargaining power of end-users, bargaining power of product developers, threat of substitute products, and rivalry among existing competitors, providing insights into the overall attractiveness, competitive intensity, and long-term growth potential of the market.
  • Market Impact Analysis: The report analyzes drivers, restraints, opportunities, and challenges affecting market growth, including the impact of regulatory fragmentation on biostimulant commercialization.

Key Questions Answered in this Report

  • How large is the agricultural biologicals market today, and how large will it be by 2035?
  • Which product types, sources and application modes are gaining or losing share?
  • Which companies are best positioned across each segment, and how deep is their product pipeline?
  • How will the shift toward biofertilizers and seed treatments reshape distribution and channel economics?
  • Which crop segments and geographies offer the strongest near-term revenue and long-term growth combination?
  • What is the realistic impact of regulatory fragmentation on biostimulant commercialization timelines?

Reasons to Buy this Report

Market players evaluating the agricultural biologicals opportunity need more than a headline market size. This report is built to support commercial decision-making, not just awareness, and differentiates itself on the following counts:

  • Top-Down and Bottom-Up Triangulated Forecasting: Revenue projections for each segment are cross-validated using both macro-level agronomic demand data and company-level sales figures, reducing forecast risk for investors and channel partners.
  • Primary Research with Senior Commercial and Technical Leadership: Insights are grounded in interviews with presidents, global directors, and heads of biologics across large, mid-sized, and specialty organizations, not desk research alone.
  • Distribution and Channel-Specific Lens: Unlike generic agri-input market reports, this study maps how the mix shift across foliar, seed, and soil application methods will change storage stability requirements, seasonal inventory planning, and retail agri-input accessibility, insights directly relevant to distributors and input retailers.
  • Regulatory-Readiness Analysis: A dedicated view of EPA and EFSA treatment of biopesticides versus the fragmented, evolving oversight of biostimulants helps distributors time market-entry and portfolio decisions around regulatory clarity.
  • Investor-Grade Financial Context: Company profiles include revenue trends, recent capital deployment (such as IPL Biologicals' expanded manufacturing capacity and BASF's AgBiTech acquisition), and funding activity, positioned for use in diligence and business case development.

Additional Benefits

  • Complementary PPT Insights Pack
  • Complementary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with Research Team
  • Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Introduction
  • 1.2. Market Share Insights
  • 1.3. Key Market Insights
  • 1.4. Report Coverage
  • 1.5. Key Questions Answered
  • 1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

  • 2.1. Chapter Overview
  • 2.2. Research Assumptions
    • 2.2.1. Market Landscape and Market Trends
    • 2.2.2. Market Forecast and Opportunity Analysis
    • 2.2.3. Comparative Analysis
  • 2.3. Database Building
    • 2.3.1. Data Collection
    • 2.3.2. Data Validation
    • 2.3.3. Data Analysis
  • 2.4. Project Methodology
    • 2.4.1. Secondary Research
      • 2.4.1.1. Annual Reports
      • 2.4.1.2. Academic Research Papers
      • 2.4.1.3. Company Websites
      • 2.4.1.4. Investor Presentations
      • 2.4.1.5. Regulatory Filings
      • 2.4.1.6. White Papers
      • 2.4.1.7. Industry Publications
      • 2.4.1.8. Conferences and Seminars
      • 2.4.1.9. Government Portals
      • 2.4.1.10. Media and Press Releases
      • 2.4.1.11. Newsletters
      • 2.4.1.12. Industry Databases
      • 2.4.1.13. Roots Proprietary Databases
      • 2.4.1.14. Paid Databases and Sources
      • 2.4.1.15. Social Media Portals
      • 2.4.1.16. Other Secondary Sources
    • 2.4.2. Primary Research
      • 2.4.2.1. Types of Primary Research
        • 2.4.2.1.1. Qualitative Research
        • 2.4.2.1.2. Quantitative Research
        • 2.4.2.1.3. Hybrid Approach
      • 2.4.2.2. Advantages of Primary Research
      • 2.4.2.3. Techniques for Primary Research
        • 2.4.2.3.1. Interviews
        • 2.4.2.3.2. Surveys
        • 2.4.2.3.3. Focus Groups
        • 2.4.2.3.4. Observational Research
        • 2.4.2.3.5. Social Media Interactions
      • 2.4.2.4. Key Opinion Leaders Considered in Primary Research
        • 2.4.2.4.1. Company Executives (CXOs)
        • 2.4.2.4.2. Board of Directors
        • 2.4.2.4.3. Company Presidents and Vice Presidents
        • 2.4.2.4.4. Research and Development Heads
        • 2.4.2.4.5. Technical Experts
        • 2.4.2.4.6. Subject Matter Experts
        • 2.4.2.4.7. Scientists
        • 2.4.2.4.8. Doctors and Other Healthcare Providers
      • 2.4.2.5. Ethics and Integrity
        • 2.4.2.5.1. Research Ethics
        • 2.4.2.5.2. Data Integrity
    • 2.4.3. Analytical Tools and Databases
  • 2.5. Robust Quality Control

3. MARKET DYNAMICS

  • 3.1. Chapter Overview
  • 3.2. Forecast Methodology
    • 3.2.1. Top-down Approach
    • 3.2.2. Bottom-up Approach
    • 3.2.3. Hybrid Approach
  • 3.3. Market Assessment Framework
    • 3.3.1. Total Addressable Market (TAM)
    • 3.3.2. Serviceable Addressable Market (SAM)
    • 3.3.3. Serviceable Obtainable Market (SOM)
    • 3.3.4. Currently Acquired Market (CAM)
  • 3.4. Forecasting Tools and Techniques
    • 3.4.1. Qualitative Forecasting
    • 3.4.2. Correlation
    • 3.4.3. Regression
    • 3.4.4. Extrapolation
    • 3.4.5. Convergence
    • 3.4.6. Sensitivity Analysis
    • 3.4.7. Scenario Planning
    • 3.4.8. Data Visualization
    • 3.4.9. Time Series Analysis
    • 3.4.10. Forecast Error Analysis
  • 3.5. Key Considerations
    • 3.5.1. Demographics
    • 3.5.2. Government Regulations
    • 3.5.3. Reimbursement Scenarios
    • 3.5.4. Market Access
    • 3.5.5. Supply Chain
    • 3.5.6. Industry Consolidation
    • 3.5.7. Pandemic / Unforeseen Disruptions Impact
  • 3.6. Limitations

4. MACRO-ECONOMIC INDICATORS

  • 4.1. Chapter Overview
  • 4.2. Market Dynamics
    • 4.2.1. Time Period
      • 4.2.1.1. Historical Trends
      • 4.2.1.2. Current and Forecasted Estimates
    • 4.2.2. Currency Coverage
      • 4.2.2.1. Major Currencies Affecting the Market
      • 4.2.2.2. Factors Affecting Currency Fluctuations
      • 4.2.2.3. Impact of Currency Fluctuations on the Industry
    • 4.2.3. Foreign Currency Exchange Rate
      • 4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market
      • 4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
    • 4.2.4. Recession
      • 4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market
      • 4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt
    • 4.2.5. Inflation
      • 4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
      • 4.2.5.2. Potential Impact of Inflation on the Market Evolution
    • 4.2.6. Interest Rates
      • 4.2.6.1. Interest Rates and Their Impact on the Market
      • 4.2.6.2. Strategies for Managing Interest Rate Risk
    • 4.2.7. Commodity Flow Analysis
      • 4.2.7.1. Type of Commodity
      • 4.2.7.2. Origins and Destinations
      • 4.2.7.3. Values and Weights
      • 4.2.7.4. Modes of Transportation
    • 4.2.8. Global Trade Dynamics
      • 4.2.8.1. Import Scenario
      • 4.2.8.2. Export Scenario
      • 4.2.8.3. Trade Policies
      • 4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers
      • 4.2.8.5. Impact of Trade Barriers on the Market
    • 4.2.9. War Impact Analysis
      • 4.2.9.1. Russian-Ukraine War
      • 4.2.9.2. Israel-Hamas War
    • 4.2.10. COVID Impact / Related Factors
      • 4.2.10.1. Global Economic Impact
      • 4.2.10.2. Industry-specific Impact
      • 4.2.10.3. Government Response and Stimulus Measures
      • 4.2.10.4. Future Outlook and Adaptation Strategies
    • 4.2.11. Other Indicators
      • 4.2.11.1. Fiscal Policy
      • 4.2.11.2. Consumer Spending
      • 4.2.11.3. Gross Domestic Product
      • 4.2.11.4. Employment
      • 4.2.11.5. Taxes
      • 4.2.11.6. Stock Market Performance
      • 4.2.11.7. Cross Border Dynamics
  • 4.3. Conclusion

5. EXECUTIVE SUMMARY

  • 5.1. Executive Summary: Market Landscape
  • 5.2. Executive Summary: Market Trends
  • 5.3. Executive Summary: Market Forecast and Opportunity Analysis

6. INTRODUCTION

  • 6.1. Chapter Overview
  • 6.2. Sustainable Agriculture
  • 6.3. Introduction to Agricultural Biologicals
    • 6.3.1. Types of Agricultural Biologicals
      • 6.3.1.1. Biostimulants
      • 6.3.1.2. Biopesticides / Biocontrol
      • 6.3.1.3. Biofertilizers
    • 6.3.2. Advantages of Agricultural Biologicals
  • 6.4. Future Perspectives

7. MARKET LANDSCAPE

  • 7.1. Chapter Overview
  • 7.2. Agricultural Biologicals Manufacturers: Overall Market Landscape
    • 7.2.1. Analysis by Year of Establishment
    • 7.2.2. Analysis by Company Size
    • 7.2.3. Analysis by Year of Establishment and Company Size
    • 7.2.4. Analysis by Location of Headquarters
    • 7.2.5. Analysis by Company Size and Location of Headquarters
    • 7.2.6. Analysis by Type of Product Offered
    • 7.2.7. Analysis by Company Size and Type of Product Offered
    • 7.2.8. Analysis by Source of Product Offered
    • 7.2.9. Analysis by Type of Product Formulation
    • 7.2.10. Analysis by Type of Crop Treated
    • 7.2.11. Analysis by Mode of Application
    • 7.2.12. Analysis by Number of Products Offered
    • 7.2.13. Most Active Players: Analysis by Number of Products Offered

8. COMPANY COMPETITIVENESS ANALYSIS

  • 8.1. Chapter Overview
  • 8.2. Assumptions and Key Parameters
  • 8.3. Methodology
  • 8.4. Company Competitiveness Analysis: Agricultural Biologicals Manufacturers in North America
    • 8.4.1. Very Small and Small Companies in North America
    • 8.4.2. Mid-sized Companies in North America
    • 8.4.3. Large and Very Large Companies in North America
  • 8.5. Company Competitiveness Analysis: Agricultural Biologicals Manufacturers in Europe
    • 8.5.1. Very Small and Small Companies in Europe
    • 8.5.2. Mid-sized Companies in Europe
    • 8.5.3. Large and Very Large Companies in Europe
  • 8.6. Company Competitiveness Analysis: Agricultural Biologicals Manufacturers in Asia-Pacific and Rest of the World
    • 8.6.1. Very Small and Small Companies in Asia-Pacific and Rest of the World
    • 8.6.2. Mid-sized Companies in Asia-Pacific and Rest of the World
    • 8.6.3. Large and Very Large Companies in Asia-Pacific and Rest of the World
  • 8.7. Company Competitiveness Analysis: Other Agricultural Biologicals Manufacturers

9. COMPANY PROFILES

  • 9.1. Chapter Overview
  • 9.2. Leading Players in Agricultural Biologicals Market
    • 9.2.1. Andermatt
      • 9.2.1.1. Company Overview
      • 9.2.1.2. Agricultural Biologicals Portfolio
      • 9.2.1.3. Recent Developments and Future Outlook
    • 9.2.2. Certis Biologicals
      • 9.2.2.1. Company Overview
      • 9.2.2.2. Agricultural Biologicals Portfolio
      • 9.2.2.3. Recent Developments and Future Outlook
    • 9.2.3. Corteva Agriscience
      • 9.2.3.1. Company Overview
      • 9.2.3.2. Financial Information
      • 9.2.3.3. Agricultural Biologicals Portfolio
      • 9.2.3.4. Recent Developments and Future Outlook
    • 9.2.4. Nutri-Tech Solutions
      • 9.2.4.1. Company Overview
      • 9.2.4.2. Agricultural Biologicals Portfolio
      • 9.2.4.3. Recent Developments and Future Outlook
    • 9.2.5. Novozymes
      • 9.2.5.1. Company Overview
      • 9.2.5.2. Financial Information
      • 9.2.5.3. Agricultural Biologicals Portfolio
      • 9.2.5.4. Recent Developments and Future Outlook
    • 9.2.6. ProFarm
      • 9.2.6.1. Company Overview
      • 9.2.6.2. Agricultural Biologicals Portfolio
      • 9.2.6.3. Recent Developments and Future Outlook
    • 9.2.7. SQM
      • 9.2.7.1. Company Overview
      • 9.2.7.2. Agricultural Biologicals Portfolio
      • 9.2.7.3. Recent Developments and Future Outlook
    • 9.2.8. UPL
      • 9.2.8.1. Company Overview
      • 9.2.8.2. Financial Information
      • 9.2.8.3. Agricultural Biologicals Portfolio
      • 9.2.8.4. Recent Developments and Future Outlook
    • 9.2.9. Vegalab
      • 9.2.9.1. Company Overview
      • 9.2.9.2. Agricultural Biologicals Portfolio
      • 9.2.9.3. Recent Developments and Future Outlook
  • 9.3. Other Leading Players in Agricultural Biologicals Market
    • 9.3.1. AMVAC
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Agricultural Biologicals Portfolio
    • 9.3.2. BASF
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Agricultural Biologicals Portfolio
    • 9.3.3. Bayer
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Agricultural Biologicals Portfolio
    • 9.3.4. BioSafe Systems
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Agricultural Biologicals Portfolio
    • 9.3.5. Brandt
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Agricultural Biologicals Portfolio
    • 9.3.6. Chr.
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Agricultural Biologicals Portfolio
    • 9.3.7. FBSciences
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Agricultural Biologicals Portfolio
    • 9.3.8. Grow Indigo
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Agricultural Biologicals Portfolio
    • 9.3.9. Koppert
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Agricultural Biologicals Portfolio
    • 9.3.10. Lallemand
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Agricultural Biologicals Portfolio
    • 9.3.11. PI Industries
      • 9.3.11.1. Company Overview
      • 9.3.11.2. Agricultural Biologicals Portfolio
    • 9.3.12. Stoller
      • 9.3.12.1. Company Overview
      • 9.3.12.2. Agricultural Biologicals Portfolio
    • 9.3.13. Syngenta
      • 9.3.13.1. Company Overview
      • 9.3.13.2. Agricultural Biologicals Portfolio
    • 9.3.14. Valent Biosciences
      • 9.3.14.1. Company Overview
      • 9.3.14.2. Agricultural Biologicals Portfolio
    • 9.3.15. Verdesian Life Sciences
      • 9.3.15.1. Company Overview
      • 9.3.15.2. Agricultural Biologicals Portfolio

10. PARTNERSHIPS AND COLLABORATIONS

  • 10.1. Chapter Overview
  • 10.2. Partnership Models
  • 10.3. Agricultural Biologicals: Recent Partnerships and Collaborations
    • 10.3.1. Analysis by Year of Partnership
    • 10.3.2. Analysis by Type of Partnership
    • 10.3.3. Analysis by Year and Type of Partnership
    • 10.3.4. Analysis by Type of Partnership and Company Size
    • 10.3.5. Analysis by Focus Area of Partnership
    • 10.3.6. Analysis by Type of Partner
    • 10.3.7. Most Active Players: Analysis by Number of Partnerships
    • 10.3.8. Analysis by Geography
      • 10.3.8.1. Local and International Agreements
      • 10.3.8.2. Intracontinental and Intercontinental Agreements

11. PATENT ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Scope and Methodology
  • 11.3. Agricultural Biologicals: Patent Analysis
    • 11.3.1. Analysis by Patent Publication Year
    • 11.3.2. Analysis by Patent Application Year
    • 11.3.3. Analysis of Granted Patents and Patent Applications by Publication Year
    • 11.3.4. Analysis by Patent Jurisdiction
    • 11.3.5. Analysis by CPC Symbols
    • 11.3.6. Analysis by Type of Applicant
    • 11.3.7. Leading Industry Players: Analysis by Number of Patents
    • 11.3.8. Leading Non-Industry Players: Analysis by Number of Patents
    • 11.3.9. Leading Individual Assignees: Analysis by Number of Patents
  • 11.4. Agricultural Biologicals: Patent Benchmarking Analysis
    • 11.4.1. Analysis by Patent Characteristics
  • 11.5. Agricultural Biologicals: Patent Valuation
  • 11.6. Leading Patents by Number of Citations

12. PORTER'S FIVE FORCES ANALYSIS

  • 12.1. Chapter Overview
  • 12.2. Methodology and Assumptions
  • 12.3. Key Parameters
    • 12.3.1. Threats of New Entrants
    • 12.3.2. Bargaining Power of End-Users
    • 12.3.3. Bargaining Power of Product Developers
    • 12.3.4. Threats of Substitute Products
    • 12.3.5. Rivalry Among Existing Competitors
  • 12.4. Concluding Remarks

13. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

  • 13.1. Chapter Overview
  • 13.2. Market Drivers
  • 13.3. Market Restraints
  • 13.4. Market Opportunities
  • 13.5. Market Challenges
  • 13.6. Conclusion

14. GLOBAL AGRICULTURAL BIOLOGICALS MARKET

  • 14.1. Chapter Overview
  • 14.2. Assumptions and Methodology
  • 14.3. Global Agricultural Biologicals Market, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
    • 14.3.1. Scenario Analysis
  • 14.4. Key Market Segmentations
  • 14.5. Dynamic Dashboard

15. AGRICULTURAL BIOLOGICALS MARKET, BY TYPE OF PRODUCT

  • 15.1. Chapter Overview
  • 15.2. Key Assumptions and Methodology
  • 15.3. Agricultural Biologicals Market: Distribution by Type of Product (USD Billion)
    • 15.3.1. Biopesticides / Biocontrol Market: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
    • 15.3.2. Biofertilizers Market: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
    • 15.3.3. Biostimulants Market: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
  • 15.4. Data Triangulation
    • 15.4.1. Insights based on Primary Research
    • 15.4.2. Insights based on Secondary Research

16. AGRICULTURAL BIOLOGICALS MARKET, BY SOURCE OF PRODUCT

  • 16.1. Chapter Overview
  • 16.2. Key Assumptions and Methodology
  • 16.3. Agricultural Biologicals Market: Distribution by Source of Product (USD Billion)
    • 16.3.1. Agricultural Biologicals Market for Microbes: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
    • 16.3.2. Agricultural Biologicals Market for Plant Extracts: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
    • 16.3.3. Agricultural Biologicals Market for Other Sources: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
  • 16.4. Data Triangulation
    • 16.4.1. Insights based on Primary Research
    • 16.4.2. Insights based on Secondary Research

17. AGRICULTURAL BIOLOGICALS MARKET, BY MODE OF APPLICATION

  • 17.1. Chapter Overview
  • 17.2. Key Assumptions and Methodology
  • 17.3. Agricultural Biologicals Market: Distribution by Mode of Application (USD Billion)
    • 17.3.1. Agricultural Biologicals Market for Foliar Sprays: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
    • 17.3.2. Agricultural Biologicals Market for Seed Treatments: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
    • 17.3.3. Agricultural Biologicals Market for Soil Treatments: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
    • 17.3.4. Agricultural Biologicals Market for Other Application Methods: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
  • 17.4. Data Triangulation
    • 17.4.1. Insights based on Primary Research
    • 17.4.2. Insights based on Secondary Research

18. AGRICULTURAL BIOLOGICALS MARKET, BY TYPE OF CROP TREATED

  • 18.1. Chapter Overview
  • 18.2. Key Assumptions and Methodology
  • 18.3. Agricultural Biologicals Market: Distribution by Type of Crop Treated (USD Billion)
    • 18.3.1. Agricultural Biologicals Market for Cereals and Pulses: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
    • 18.3.2. Agricultural Biologicals Market for Fruits and Nuts: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
    • 18.3.3. Agricultural Biologicals Market for Oilseeds: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
    • 18.3.4. Agricultural Biologicals Market for Green Fodder, Vegetables and Tubers: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
    • 18.3.5. Agricultural Biologicals Market for Industrial Crops, Textile Crops and Others: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
  • 18.4. Data Triangulation
    • 18.4.1. Insights based on Secondary Research

19. AGRICULTURAL BIOLOGICALS MARKET, BY GEOGRAPHY

  • 19.1. Chapter Overview
  • 19.2. Key Assumptions and Methodology
  • 19.3. Agricultural Biologicals Market: Distribution by Key Geographical Regions (USD Billion)
    • 19.3.1. Agricultural Biologicals Market for North America: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
    • 19.3.2. Agricultural Biologicals Market for Europe: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
    • 19.3.3. Agricultural Biologicals Market for Asia-Pacific: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
    • 19.3.4. Agricultural Biologicals Market for Latin America: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
    • 19.3.5. Agricultural Biologicals Market for Middle East and North Africa: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
  • 19.4. Data Triangulation
    • 19.4.1. Insights based on Primary Research
    • 19.4.2. Insights based on Secondary Research

20. CONCLUSION

21. EXECUTIVE INSIGHTS

22. APPENDIX 1: TABULATED DATA

List of Tables

  • Table 6.1 List of Agricultural Biological Manufacturers
  • Table 6.2 Agricultural Biological Manufacturers: Information on Type of Product Offered
  • Table 6.3 Agricultural Biological Manufacturers: Information on Number of Products Offered, Source of Product Offered and Type of Product Formulation
  • Table 6.4 Agricultural Biological Manufacturers: Information on Type of Crop Treated
  • Table 6.5 Agricultural Biological Manufacturers: Information on Mode of Application
  • Table 8.1 Agricultural Biological Providers: List of Companies Profiled
  • Table 8.2 Andermatt: Company Overview
  • Table 8.3 Andermatt: Agricultural Biologicals Portfolio
  • Table 8.4 Andermatt: Recent Developments and Future Outlook
  • Table 8.5 Certis Biologicals: Company Overview
  • Table 8.6 Certis Biologicals: Agricultural Biologicals Portfolio
  • Table 8.7 Certis Biologicals: Recent Developments and Future Outlook
  • Table 8.8 Corteva Agriscience: Company Overview
  • Table 8.9 Corteva Agriscience: Agricultural Biologicals Portfolio
  • Table 8.10 Corteva Agriscience: Recent Developments and Future Outlook
  • Table 8.11 Nutri-Tech Solutions: Company Overview
  • Table 8.12 Nutri-Tech Solutions: Agricultural Biologicals Portfolio
  • Table 8.13 Novozymes: Company Overview
  • Table 8.14 Novozymes: Agricultural Biologicals Portfolio
  • Table 8.15 Novozymes: Recent Developments and Future Outlook
  • Table 8.16 ProFarm: Company Overview
  • Table 8.17 ProFarm: Agricultural Biologicals Portfolio
  • Table 8.18 ProFarm: Recent Developments and Future Outlook
  • Table 8.19 SQM: Company Overview
  • Table 8.20 SQM: Agricultural Biologicals Portfolio
  • Table 8.21 SQM: Recent Developments and Future Outlook
  • Table 8.22 UPL: Company Overview
  • Table 8.23 UPL: Agricultural Biologicals Portfolio
  • Table 8.24 UPL: Recent Developments and Future Outlook
  • Table 8.25 Vegalab: Company Overview
  • Table 8.26 Vegalab: Agricultural Biologicals Portfolio
  • Table 8.27 AMVAC: Company Overview
  • Table 8.28 AMVAC: Agricultural Biologicals Portfolio
  • Table 8.29 BASF: Company Overview
  • Table 8.30 BASF: Agricultural Biologicals Portfolio
  • Table 8.31 Bayer: Company Overview
  • Table 8.32 Bayer: Agricultural Biologicals Portfolio
  • Table 8.33 BioSafe Systems: Company Overview
  • Table 8.34 BioSafe Systems: Agricultural Biologicals Portfolio
  • Table 8.35 Brandt: Company Overview
  • Table 8.36 Brandt: Agricultural Biologicals Portfolio
  • Table 8.37 Chr. Hansen: Company Overview
  • Table 8.38 Chr. Hansen: Agricultural Biologicals Portfolio
  • Table 8.39 FBSciences: Company Overview
  • Table 8.40 FBSciences: Agricultural Biologicals Portfolio
  • Table 8.41 Grow Indigo: Company Overview
  • Table 8.42 Grow Indigo: Agricultural Biologicals Portfolio
  • Table 8.43 Koppert: Company Overview
  • Table 8.44 Koppert: Agricultural Biologicals Portfolio
  • Table 8.45 Lallemand: Company Overview
  • Table 8.46 Lallemand: Agricultural Biologicals Portfolio
  • Table 8.47 PI Industries: Company Overview
  • Table 8.48 PI Industries: Agricultural Biologicals Portfolio
  • Table 8.49 Stoller: Company Overview
  • Table 8.50 Stoller: Agricultural Biologicals Portfolio
  • Table 8.51 Syngenta: Company Overview
  • Table 8.52 Syngenta: Agricultural Biologicals Portfolio
  • Table 8.53 Valent Biosciences: Company Overview
  • Table 8.54 Valent Biosciences: Agricultural Biologicals Portfolio
  • Table 8.55 Verdisian Life Sciences: Company Overview
  • Table 8.56 Verdisian Life Sciences: Agricultural Biologicals Portfolio
  • Table 9.1 Agricultural Biologicals Market: List of Partnerships and Collaborations, Since 2020
  • Table 10.1 Patent Analysis: Top CPC Sections
  • Table 10.2 Patent Analysis: Top CPC Symbols
  • Table 10.3 Patent Analysis: Top CPC Codes
  • Table 10.4 Patent Analysis: Summary of Benchmarking Analysis
  • Table 10.5 Patent Analysis: Categorization based on Weighted Valuation Scores
  • Table 10.6 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
  • Table 10.7 Patent Portfolio: List of Leading Patents (by Number of Citations)
  • Table 20.1 Vegalab: Company Snapshot
  • Table 20.2 Acadian Plant Health: Company Snapshot
  • Table 20.3 Jiahe Biology: Company Snapshot
  • Table 21.1 Agricultural Biologicals Manufacturers: Distribution by Year of Establishment
  • Table 21.2 Agricultural Biological Manufacturers: Distribution by Company Size
  • Table 21.3 Agricultural Biological Manufacturers: Distribution by Year of Establishment and Company Size
  • Table 21.4 Agricultural Biological Manufacturers: Distribution by Location of Headquarters (Region-wise)
  • Table 21.5 Agricultural Biological Manufacturers: Distribution by Location of Headquarters (Country-wise)
  • Table 21.6 Agricultural Biological Manufacturers: Distribution by Company Size and Location of Headquarters (Region-wise)
  • Table 21.7 Agricultural Biological Manufacturers: Distribution by Type of Product Offered
  • Table 21.8 Agricultural Biological Manufacturers: Distribution by Type of Biostimulant Offered
  • Table 21.9 Agricultural Biological Manufacturers: Distribution by Type of Biopesticide / Biocontrol Offered
  • Table 21.10 Agricultural Biological Manufacturers: Distribution by Type of Biofertilizer Offered
  • Table 21.11 Agricultural Biological Manufacturers: Distribution by Company Size and Type of Product Offered
  • Table 21.12 Agricultural Biological Manufacturers: Distribution by Source of Product Offered
  • Table 21.13 Agricultural Biological Manufacturers: Distribution by Type of Product Formulation
  • Table 21.14 Agricultural Biological Manufacturers: Distribution by Type of Crop Treated
  • Table 21.15 Agricultural Biological Manufacturers: Distribution by Mode of Application
  • Table 21.16 Agricultural Biological Manufacturers: Distribution by Number of Products Offered
  • Table 21.17 Most Active Players: Distribution by the Number of Products Offered
  • Table 21.18 Corteva Agriscience: Annual Revenues, Since FY 2019 (USD Million)
  • Table 21.19 Novozymes: Annual Revenues, Since FY 2019 (DKK Million)
  • Table 21.20 UPL: Annual Revenues, Since FY 2019 (INR Crore)
  • Table 21.21 Partnerships and Collaborations: Distribution by Year of Partnership, Since 2020
  • Table 21.22 Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 21.23 Partnerships and Collaborations: Distribution by Year and Type of Partnership
  • Table 21.24 Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
  • Table 21.25 Partnerships and Collaborations: Distribution by Focus Area of Partnerships
  • Table 21.26 Partnerships and Collaborations: Distribution by Type of Partner
  • Table 21.27 Most Active Players: Distribution by Number of Partnerships
  • Table 21.28 Partnerships and Collaborations: Local and International Agreements
  • Table 21.29 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
  • Table 21.30 Patent Analysis: Distribution by Type of Patent
  • Table 21.31 Patent Analysis: Distribution by Patent Publication Year, Since 2019
  • Table 21.32 Patent Analysis: Distribution by Patent Application Year, Since Pre-2015
  • Table 21.33 Patent Analysis: Distribution of Granted Patents and Patent Applications by Publication Year, Since 2019
  • Table 21.34 Patent Analysis: Distribution by Patent Jurisdiction (Region-wise)
  • Table 21.35 Patent Analysis: Distribution by Patent Jurisdiction (Country-wise)
  • Table 21.36 Patent Analysis: Distribution by CPC Symbols
  • Table 21.37 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant, Since 2019
  • Table 21.38 Leading Industry Players: Distribution by Number of Patents
  • Table 21.39 Leading Non-Industry Players: Distribution by Number of Patents
  • Table 21.40 Leading Individual Assignees: Distribution by Number of Patents
  • Table 21.41 Patent Benchmarking Analysis: Distribution of Leading Industry Player by Patent Characteristics (CPC Codes)
  • Table 21.42 Patent Analysis: Distribution by Patent Age
  • Table 21.43 Agricultural Biologicals: Patent Valuation
  • Table 21.44 Global Agricultural Biologicals Market, Historical Trends (Since 2019) (USD Billion)
  • Table 21.45 Global Agricultural Biologicals Market, Forecasted Estimates (Till 2035): Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.46 Agricultural Biologicals Market: Distribution by Type of Product (USD Billion)
  • Table 21.47 Biopesticides / Biocontrol Market: Historical Trends (Since 2019) (USD Billion)
  • Table 21.48 Biopesticides / Biocontrol Market: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.49 Biofertilizers Market: Historical Trends (Since 2019) (USD Billion)
  • Table 21.50 Biofertilizers Market: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.51 Biostimulants Market: Historical Trends (Since 2019) (USD Billion)
  • Table 21.52 Biostimulants Market: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.53 Agricultural Biologicals Market: Distribution by Source of Product (USD Billion)
  • Table 21.54 Agricultural Biologicals Market for Microbes: Historical Trends (Since 2019) (USD Billion)
  • Table 21.55 Agricultural Biologicals Market for Microbes: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.56 Agricultural Biologicals Market for Plant Extracts: Historical Trends (Since 2019) (USD Billion)
  • Table 21.57 Agricultural Biologicals Market for Plant Extracts: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.58 Agricultural Biologicals Market for Other Sources: Historical Trends (Since 2019) (USD Billion)
  • Table 21.59 Agricultural Biologicals Market for Other Sources: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.60 Agricultural Biologicals Market: Distribution by Mode of Application (USD Billion)
  • Table 21.61 Agricultural Biologicals Market for Foliar Sprays: Historical Trends (Since 2019) (USD Billion)
  • Table 21.62 Agricultural Biologicals Market for Foliar Sprays: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.63 Agricultural Biologicals Market for Seed Treatments: Historical Trends (Since 2019) (USD Billion)
  • Table 21.64 Agricultural Biologicals Market for Seed Treatments: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.65 Agricultural Biologicals Market for Soil Treatments: Historical Trends (Since 2019) (USD Billion)
  • Table 21.66 Agricultural Biologicals Market for Soil Treatments: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.67 Agricultural Biologicals Market for Other Application Methods: Historical Trends (Since 2019) (USD Billion)
  • Table 21.68 Agricultural Biologicals Market for Other Application Methods: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.69 Agricultural Biologicals Market: Distribution by Type of Crop Treated (USD Billion)
  • Table 21.70 Agricultural Biologicals Market for Cereals and Pulses: Historical Trends (Since 2019) (USD Billion)
  • Table 21.71 Agricultural Biologicals Market for Cereals and Pulses: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.72 Agricultural Biologicals Market for Fruits and Nuts: Historical Trends (Since 2019) (USD Billion)
  • Table 21.73 Agricultural Biologicals Market for Fruits and Nuts: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.74 Agricultural Biologicals Market for Oilseeds: Historical Trends (Since 2019) (USD Billion)
  • Table 21.75 Agricultural Biologicals Market for Oilseeds: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.76 Agricultural Biologicals Market for Green Fodder, Vegetables and Tubers: Historical Trends (Since 2019) (USD Billion)
  • Table 21.77 Agricultural Biologicals Market for Green Fodder, Vegetables and Tubers: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.78 Agricultural Biologicals Market for Industrial Crops, Textile Crops and Others: Historical Trends (Since 2019) (USD Billion)
  • Table 21.79 Agricultural Biologicals Market for Industrial Crops, Textile Crops and Others: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.80 Agricultural Biologicals Market: Distribution by Key Geographical Regions (USD Billion)
  • Table 21.81 Agricultural Biologicals Market for North America: Historical Trends (Since 2019) (USD Billion)
  • Table 21.82 Agricultural Biologicals Market for North America: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.83 Agricultural Biologicals Market for Europe: Historical Trends (Since 2019) (USD Billion)
  • Table 21.84 Agricultural Biologicals Market for Europe: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.85 Agricultural Biologicals Market for Asia-Pacific: Historical Trends (Since 2019) (USD Billion)
  • Table 21.86 Agricultural Biologicals Market for Asia-Pacific: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.87 Agricultural Biologicals Market for Latin America: Historical Trends (Since 2019) (USD Billion)
  • Table 21.88 Agricultural Biologicals Market for Latin America: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 21.89 Agricultural Biologicals Market for Middle East and North Africa: Historical Trends (Since 2019) (USD Billion)
  • Table 21.90 Agricultural Biologicals Market for Middle East and North Africa: Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)

List of Figures

  • Figure 2.1 Research Methodology: Research Assumptions
  • Figure 2.2 Research Methodology: Project Methodology
  • Figure 2.3 Research Methodology: Forecast Methodology
  • Figure 2.4 Research Methodology: Robust Quality Control
  • Figure 2.5 Research Methodology: Key Market Segmentations
  • Figure 3.1 Lessons Learnt from Past Recessions
  • Figure 4.1 Executive Summary: Agricultural Biologicals Market Landscape
  • Figure 4.2 Executive Summary: Partnerships and Collaborations
  • Figure 4.3 Executive Summary: Patent Analysis
  • Figure 4.4 Executive Summary: Market Forecast and Opportunity Analysis
  • Figure 5.1 Differences between Conventional and Sustainable Agricultural Practices
  • Figure 5.2 Types of Agricultural Biologicals
  • Figure 5.3 Types of Biostimulants
  • Figure 5.4 Types of Biopesticides
  • Figure 5.5 Types of Biofertilizers
  • Figure 5.6 Advantages of Agricultural Biologicals
  • Figure 6.1 Agricultural Biological Manufacturers: Distribution by Year of Establishment
  • Figure 6.2 Agricultural Biological Manufacturers: Distribution by Company Size
  • Figure 6.3 Agricultural Biological Manufacturers: Distribution by Year of Establishment and Company Size
  • Figure 6.4 Agricultural Biological Manufacturers: Distribution by Location of Headquarters (Region)
  • Figure 6.5 Agricultural Biological Manufacturers: Distribution by Location of Headquarters (Country)
  • Figure 6.6 Agricultural Biological Manufacturers: Distribution by Company Size and Location of Headquarters (Region)
  • Figure 6.7 Agricultural Biological Manufacturers: Distribution by Type of Product Offered
  • Figure 6.8 Agricultural Biological Manufacturers: Distribution by Type of Biostimulant Offered
  • Figure 6.9 Agricultural Biological Manufacturers: Distribution by Type of Biopesticide / Biocontrol Offered
  • Figure 6.10 Agricultural Biological Manufacturers: Distribution by Type of Biofertilizer Offered
  • Figure 6.11 Agricultural Biological Manufacturers: Distribution by Company Size and Type of Product Offered
  • Figure 6.12 Agricultural Biological Manufacturers: Distribution by Source of Product Offered
  • Figure 6.13 Agricultural Biological Manufacturers: Distribution by Type of Product Formulation
  • Figure 6.14 Agricultural Biological Manufacturers: Distribution by Type of Crop Treated
  • Figure 6.15 Agricultural Biological Manufacturers: Distribution by Mode of Application
  • Figure 6.16 Agricultural Biological Manufacturers: Distribution by Number of Products Offered
  • Figure 6.17 Most Active Players: Distribution by the Number of Products Offered
  • Figure 7.1 Company Competitiveness Analysis: Very Small and Small Companies in North America
  • Figure 7.2 Company Competitiveness Analysis: Mid-sized Companies in North America
  • Figure 7.3 Company Competitiveness Analysis: Large and Very Large Companies in North America
  • Figure 7.4 Company Competitiveness Analysis: Very Small and Small Companies in Europe
  • Figure 7.5 Company Competitiveness Analysis: Mid-Sized Companies in Europe
  • Figure 7.6 Company Competitiveness Analysis: Large and Very Large Companies in Europe
  • Figure 7.7 Company Competitiveness Analysis: Very Small and Small Companies in Asia-Pacific and Rest of the World
  • Figure 7.8 Company Competitiveness Analysis: Mid-sized Companies in Asia-Pacific and Rest of the World
  • Figure 7.9 Company Competitiveness Analysis: Large and Very Large Companies in Asia-Pacific and Rest of the World
  • Figure 7.10 Company Competitiveness Analysis: Other Agricultural Biological Manufacturers
  • Figure 8.1 Corteva Agriscience: Annual Revenues, Since FY 2019 (USD Million)
  • Figure 8.2 Novozymes: Annual Revenues, Since FY 2019 (DKK Million)
  • Figure 8.3 UPL: Annual Revenues, Since FY 2019 (INR Crore)
  • Figure 9.1 Partnerships and Collaborations: Distribution by Year of Partnership, Since 2020
  • Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
  • Figure 9.4 Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
  • Figure 9.5 Partnerships and Collaborations: Distribution by Focus Area of Partnerships
  • Figure 9.6 Partnerships and Collaborations: Distribution by Type of Partner
  • Figure 9.7 Most Active Players: Distribution by Number of Partnerships
  • Figure 9.8 Partnerships and Collaborations: Local and International Agreements
  • Figure 9.9 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
  • Figure 10.1 Patent Analysis: Distribution by Type of Patent
  • Figure 10.2 Patent Analysis: Distribution by Patent Publication Year, Since 2019
  • Figure 10.3 Patent Analysis: Distribution by Patent Application Year, Since Pre-2015
  • Figure 10.4 Patent Analysis: Distribution of Granted Patents and Patent Applications by Publication Year, Since 2019
  • Figure 10.5 Patent Analysis: Distribution by Patent Jurisdiction (Region-wise)
  • Figure 10.6 Patent Analysis: Distribution by Patent Jurisdiction (Country-wise)
  • Figure 10.7 Patent Analysis: Distribution by CPC Symbols
  • Figure 10.8 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant, Since 2019
  • Figure 10.9 Leading Industry Players: Distribution by Number of Patents
  • Figure 10.10 Leading Non-Industry Players: Distribution by Number of Patents
  • Figure 10.11 Leading Individual Assignees: Distribution by Number of Patents
  • Figure 10.12 Patent Benchmarking Analysis: Distribution of Leading Industry Player by Patent Characteristics (CPC Codes)
  • Figure 10.13 Patent Analysis: Distribution by Patent Age
  • Figure 10.14 Agricultural Biologicals: Patent Valuation
  • Figure 11.1 Porter's Five Forces: Key Parameters
  • Figure 11.2 Threats of New Entrants: Key Factors
  • Figure 11.3 Bargaining Power of End-Users: Key Factors
  • Figure 11.4 Bargaining Power of Product Developers: Key Factors
  • Figure 11.5 Threats of Substitute Products: Key Factors
  • Figure 11.6 Rivalry Among Existing Competitors: Key Factors
  • Figure 11.7 Porter's Five Forces: Concluding Remarks
  • Figure 12.1 Market Impact Analysis: Drivers, Restraints, Opportunities and Challenges
  • Figure 13.1 Global Agricultural Biologicals Market, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035): Base Scenario (USD Billion)
  • Figure 13.2 Global Agricultural Biologicals Market, Forecasted Estimates (Till 2035), Conservative Scenario (USD Billion)
  • Figure 13.3 Global Agricultural Biologicals Market, Forecasted Estimates (Till 2035), Optimistic Scenario (USD Billion)
  • Figure 14.1 Agricultural Biologicals Market: Distribution by Type of Product (USD Billion)
  • Figure 14.2 Biopesticides / Biocontrol Market: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 14.3 Biofertilizers Market: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 14.4 Biostimulants Market: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.1 Agricultural Biologicals Market: Distribution by Source of Product (USD Billion)
  • Figure 15.2 Agricultural Biologicals Market for Microbes: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.3 Agricultural Biologicals Market for Plant Extracts: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.4 Agricultural Biologicals Market for Other Sources: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 16.1 Agricultural Biologicals Market: Distribution by Mode of Application (USD Billion)
  • Figure 16.2 Agricultural Biologicals Market for Foliar Sprays: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 16.3 Agricultural Biologicals Market for Seed Treatments: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 16.4 Agricultural Biologicals Market for Soil Treatments: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 16.5 Agricultural Biologicals Market for Other Application Methods: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 17.1 Agricultural Biologicals Market: Distribution by Type of Crop Treated (USD Billion)
  • Figure 17.2 Agricultural Biologicals Market for Cereals and Pulses: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 17.3 Agricultural Biologicals Market for Fruits and Nuts: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 17.4 Agricultural Biologicals Market for Oilseeds: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 17.5 Agricultural Biologicals Market for Green Fodder, Vegetables and Tubers: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 17.6 Agricultural Biologicals Market for Industrial Crops, Textile Crops and Others: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 18.1 Agricultural Biologicals Market: Distribution by Key Geographical Regions (USD Billion)
  • Figure 18.2 Agricultural Biologicals Market for North America: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 18.3 Agricultural Biologicals Market for Europe: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 18.4 Agricultural Biologicals Market for Asia-Pacific: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 18.5 Agricultural Biologicals Market for Latin America: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 18.6 Agricultural Biologicals Market for Middle East and North Africa: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 19.1 Conclusion: Agricultural Biologicals Market Landscape
  • Figure 19.2 Conclusion: Partnerships and Collaborations
  • Figure 19.3 Conclusion: Patent Analysis
  • Figure 19.4 Conclusion: Porter's Five Forces Analysis
  • Figure 19.5 Conclusion: Market Forecast and Opportunity Analysis